Market Overview

What Does AstraZeneca's Debt Look Like?


Over the past three months, shares of AstraZeneca (NASDAQ: AZN) increased by 2.08%. Before we understand the importance of debt, let us look at how much debt AstraZeneca has.

AstraZeneca's Debt

According to the AstraZeneca’s most recent financial statement as reported on July 28, 2016, total debt is at $19.00 billion, with $16.95 billion in long-term debt and $2.06 billion in current debt. Adjusting for $3.92 billion in cash-equivalents, the company has a net debt of $15.09 billion.

Investors look at the debt-ratio to understand how much financial leverage a company has. AstraZeneca has $64.42 billion in total assets, therefore making the debt-ratio 0.3. Generally speaking, a debt-ratio more than one means that a large portion of debt is funded by assets. As the debt-ratio increases, so the does the risk of defaulting on loans, if interest rates were to increase. Different industries have different thresholds of tolerance for debt-ratios. A debt ratio of 35% might be higher for one industry and normal for another.

Why Debt Is Important

Besides equity, debt is an important factor in the capital structure of a company, and contributes to its growth. Due to its lower financing cost compared to equity, it becomes an attractive option for executives trying to raise capital.

However, interest-payment obligations can have an adverse impact on the cash-flow of the company. Having financial leverage also allows companies to use additional capital for business operations, allowing equity owners to retain excess profit, generated by the debt capital.


Related Articles (AZN)

View Comments and Join the Discussion!

Posted-In: Debt InsightsNews Intraday Update Markets